Clofazimine

CHEMBL1292 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
473.4 g/mol
LogP
7.1
Phase
4

A fat-soluble riminophenazine dye antibiotic with anti-inflammatory properties used primarily to treat leprosy and drug-resistant tuberculosis. It accumulates in fatty tissues and skin, giving patients a reddish-brown discoloration during treatment.

분자량

473.4000 g/mol

LogP

7.10

TPSA

40.00 Ų

리핀스키 5의 법칙

통과

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1

InChI

InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3/b30-24+

Molecular Formula

C27H22Cl2N4

HBD / HBA

1 / 4

회전 가능 결합

4

무거운 원자

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A fat-soluble riminophenazine dye antibiotic with anti-inflammatory properties used primarily to treat leprosy and drug-resistant tuberculosis. It accumulates in fatty tissues and skin, giving patients a reddish-brown discoloration during treatment.

Yes, Clofazimine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1292. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2794. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.